A metabolic approach to the management of ischemic heart disease. Clinical benefits with trimetazidine

American Journal of Cardiovascular Drugs

Volumn 3, Issue SUPPL. 1, 2003, Pages 27-33

  Jackson, Graham ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A ACYLTRANSFERASE; ACETYLSALICYLIC ACID; AMLODIPINE; ANTILIPEMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DOBUTAMINE; FELODIPINE; GLUCOSE; LACTIC ACID; METOPROLOL; NICARDIPINE; NIFEDIPINE; NISOLDIPINE; NITRIC ACID DERIVATIVE; POTASSIUM CHANNEL STIMULATING AGENT; PROPRANOLOL; TRIMETAZIDINE;

ARTERY DILATATION; BLOOD PRESSURE REGULATION; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; DRUG MECHANISM; ENZYME INHIBITION; FATTY ACID OXIDATION; GASTROINTESTINAL DISEASE; GLUCOSE OXIDATION; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; HEART RATE; HEART VENTRICLE PRESSURE; HEMODYNAMICS; HUMAN; ISCHEMIC HEART DISEASE; NAUSEA AND VOMITING; PRIORITY JOURNAL; REVIEW; VEIN DILATATION;

EID: 0037247750     PISSN: 11753277     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129784-200303001-00004     Document Type: Review

References (32)

1. Jackson G. Combination therapy in angina: a review of combined haemodynamic treatment and the role for combined haemodynamic and cardiac metabolic agents. Int J Clin Pract 2001; 55: 256-61
2. Stanley WC, Lopaschuk GD, Hall JL, et al. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions: potential for pharmacological interventions. Cardiovasc Res 1997; 33: 243-57
3. Lopaschuk GD, Stanley WC. Glucose metabolism in the ischaemic heart [editorial]. Circulation 1997; 95: 313-5
4. Jackson G. Clinical benefits of a metabolic approach to the management of coronary patients. Eur Heart J Suppl O 1999; 1: O28-31
5. Kantor PF, Lucien A, Kozak R, et al. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res 2000; 86: 580-8
6. Sellier P, Audouin P, Payen B, et al. Acute effects of trimetazidine evaluated by exercise testing. Eur J Clin Pharmacol 1987; 33: 205-7
7. Sellier P. The effects of trimetazidine on ergometric parameters in exercise-induced angina. Controlled multicenter double blind versus placebo study [in French]. Arch Mal Coeur Vaiss 1986; 79: 1331-6
8. Chierchia SL. Dobutamine stress echocardiography and the effects of trimetazidine on left ventricular dysfunction in patients with coronary artery disease. Coron Artery Dis 2001; 12 Suppl. 1: S19-21
9. Detry JM, Sellier P, Pennaforte S, et al. Trimetazidine: a new concept in the treatment of angina: comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group. Br J Clin Pharmacol 1994; 37: 279-88
10. Dalla-Volta S, Maraglino G, Della-Valentina P, et al. Comparison of trimetazidine with nifedipine in effort angina: a double-blind, crossover study. Cardiovasc Drugs Ther 1990; 4 Suppl. 4: 853-9
11. Michaelides AP, Spiropoulos K, Dimopoulos K, et al. Anti-anginal efficacy of the combination of trimetazidine-propranolol compared with isosorbide dinitrate-propranolol in patients with stable angina. Clin Drug Invest 1997; 13: 8-14
12. Manchanda SC, Krishnasawami S. Combination treatment of trimetazidine and diltiazem in stable angina pectoris. Heart 1997; 78: 353-7
13. Levy S. Combination therapy of trimetazidine with diltiazem in patients with coronary artery disease. Group of South of France Investigators. Am J Cardiol 1995; 76 (6): 12B-6B
14. Szwed H, Pachocki R, Domzal-Bochenska M, et al. Efficacy and tolerance of trimetazidine in combination with a conventional anti-anginal drug in patients with stable effort angina. Diagn Treat Cardiol 1997; 4: 237-47
15. Szwed H, Sadowski Z, Elikowski W, et al. Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study. (TRIMPOL II). TRIMetazidine in POLand. Eur Heart J 2001; 22: 2267-74
16. Dunselman PH, van Kempen LH, Bouwens LH, et al. Value of the addition of amlodipine to atenolol in patients with angina pectoris despite adequate beta-blockade. Am J Cardiol 1998; 81: 128-32
17. Dunselman P, Liem AH, Verdel G, et al. Addition of felodipine to metoprolol vs replacement of metoprolol by felodipine in patients with angina pectoris despite adequate beta-blockade. Results of the Felodipine ER and Metoprolol CR in Angina (FEMINA) Study. Working Group on Cardiovascular Research, The Netherlands (WCN). Eur Heart J 1997; 18: 1735-64
18. el-Tamimi H, Davies GJ. Optimal control of myocardial ischaemia: the benefit of a fixed combination of atenolol and nifedipine in patients with chronic stable angina. Br Heart J 1992; 68: 291-5
19. Knight CJ, Fox KM. Amlodipine versus diltiazem as additional anti-anginal treatment to atenolol. Centralised European Studies in Angina Research (CESAR) Investigators. Am J Cardiol 1998; 81: 133-6
20. Toal CB, Motro M, Baird MG, et al. Effectiveness of nifedipine GITS in combination with atenolol in chronic stable angina. Can J Cardiol 1999; 15: 1103-9
21. Fox KM, Mulcahy D, Findlay I, et al. The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and total ischaemic burden in 608 patients with stable angina. The TIBET Study Group. Eur Heart J 1996; 17: 96-103
22. Savonitto S, Ardissiono D, Egstrup K, et al. Combination therapy with metoprolol and nifedipine versus mono-therapy in patients with stable angina pectoris: results of the International Multicentre Angina Exercise (IMAGE) Study. J Am Coll Cardiol 1996; 17: 311-6
23. Madjlessi-Simon T, Fillette F, Mary-Krause M, et al. Effects of amlodipine on transient myocardial ischaemia in patients with a severe coronary condition treated with a beta-blocker. Amlor Holter Study Investigators. Eur Heart J 1995; 16: 1780-8
24. Meyer TE, Adnams C, Commerford P. Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina. Cardiovasc Drugs Ther 1993; 7: 909-13
25. Donaldson KM, Dawkins KD, Waller DG. A comparison of nisoldipine and nifedipine, in combination with atenolol, in the management of myocardial ischaemia. Eur Heart J 1993; 14: 534-9
26. Parameshwar J, Keegan J, Mulcahy D, et al. Atenolol or nicardipine alone is as efficacious in stable angina as their combination: a double-blind randomised trial. Int J Cardiol 1993; 40: 135-41
27. Ferguson JD, Ormerod O, Lenox-Smith AJ. Bisoprolol alone and in combination with amlodipine or nifedipine in the treatment of chronic stable angina. Int J Clin Pract 2000; 54 (6): 360-3
28. Szwed H, Sadowski Z, Pachocki R, et al. Anti-ischaemic efficacy and tolerability of trimetazidine in elderly patients with angina pectoris: a sub-study from TRIMPOL-1 (Trimetazidine in Poland). Clin Drug Invest 2000; 19: 1-8
29. Szwed H, Sadowski Z, Packocki R, et al. The antiischaemic effects and tolerability of trimetazidine in coronary diabetic patients: a substudy from TRIMPOL I. Cardiovasc Drugs Ther 1999; 13: 217-22
30. Pogatsa G. Metabolic energy metabolism in diabetes: therapeutic implications. Coron Artery Dis 2001; 12 Suppl. 1: S29-33
31. Belardinelli R, Purcaro A. Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy. Eur Heart J 2001; 22: 2164-70
32. McClellan KJ, Plosker GL. Trimetazidine: a review of its use in stable angina pectoris and other coronary conditions. Drugs 1999; 58: 143-57.